Recent News Releases
This section includes a wide variety of news including media releases, photo and video galleries, fact sheets and publications.
- Long-term efficacy and safety of ertugliflozin monotherapy in patients with inadequately controlled T2DM despite diet and exercise: VERTIS MONO extension study
- Periprocedural management of anticoagulation for atrial fibrillation catheter ablation in direct oral anticoagulant–treated patients
- Malignancy development risk in psoriatic arthritis patients undergoing treatment: A systematic review and meta-analysis
- Phase II study of everolimus and octreotide LAR in patients with nonfunctioning gastrointestinal neuroendocrine tumors: The GETNE1003_EVERLAR study
- A randomized, controlled phase I/II study to evaluate the safety and efficacy of MGV354 for ocular hypertension or glaucoma
PHARMACOLOGY
- Antibiotic therapy for preventing infections in people with acute stroke
- Management of major bleeding and outcomes in patients treated with direct oral anticoagulants: Results from the START-Event registry
- Effect of canagliflozin on left ventricular diastolic function in patients with type 2 diabetes
- Effects of clopidogrel with or without aspirin on the generation of extracellular vesicles in the microcirculation and in venous blood: A randomized placebo controlled trial
- Insufficient left ventricular unloading after extracorporeal membrane oxygenation
CLINICAL PHARMACOLOGY
- Efficacy and safety of curcumin in treatment of intestinal adenomas in patients with familial adenomatous polyposis
- Hepatic resection compared to chemoembolization in intermediate- to advanced-stage hepatocellular carcinoma: A meta-analysis of high-quality studies
- Low-grade intraductal carcinoma of the salivary gland with prominent oncocytic change: A newly described variant
- Malignancy development risk in psoriatic arthritis patients undergoing treatment: A systematic review and meta-analysis
- Effect of more vs less frequent follow-up testing on overall and colorectal cancer–specific mortality in patients with stage II or III colorectal cancer: The COLOFOL Randomized Clinical Trial
ONCOLOGY